Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xtant Medical Holdings, Inc.XTNT · Entity 7196 | Director | July 25, 2017 | July 27, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xtant Medical Holdings, Inc.
Report date July 25, 2017 · Filed July 27, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 318,641 |
Reported balance
After 2017-07-25 transaction · row 1
1 source rowRow 1 · 2017-07-25 · Grant · Acquired 51,948 · Balance 318,641 F1: The common stock vests on July 25, 2018. |
| Common StockSEC Table I · non-derivative | IndirectBy Limited Partnership | 20,000 |
Reported balance
Holding disclosure · report date 2017-07-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock vests on July 25, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2017 Filed Jul 27, 2017 15:04 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock | 51,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-038572 · v471656_4.xml · nonDerivative · entry 1 Swanson Kent L · CIK 0001298906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,641 F1 · shares: The common stock vests on July 25, 2018. Read SEC document |
| November 17, 2016 Filed Nov 24, 2016 00:40 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | OtherWarrants (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.90 | Not disclosed |
DisclosureSEC source: 0001144204-16-136458 · v453904_4.xml · derivative · entry 4 Swanson Kent L · CIK 0001298906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2021-11-17 F1 · price: The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by the Issuer to all holders of the Issuer's common stock and outstanding convertible notes. Each holder received 2 subscription rights per share of stock owned, and each right allowed the recipient to purchase one unit, consisting of one share of common stock and one warrant to purchase one share of common stock. The subscription price per unit was $0.75. F2 · derivative.underlying: Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $0.90 from the date of issuance through November 17, 2021. Read SEC document |
| November 17, 2016 Filed Nov 24, 2016 00:40 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | OtherCommon Stock | 150,000 | $0.75 | $112,500.00 |
DisclosureSEC source: 0001144204-16-136458 · v453904_4.xml · nonDerivative · entry 1 Swanson Kent L · CIK 0001298906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,693 F1 · price: The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by the Issuer to all holders of the Issuer's common stock and outstanding convertible notes. Each holder received 2 subscription rights per share of stock owned, and each right allowed the recipient to purchase one unit, consisting of one share of common stock and one warrant to purchase one share of common stock. The subscription price per unit was $0.75. Read SEC document |
| November 14, 2016 Filed Nov 24, 2016 00:40 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | OtherSubscription Rights (right to receive) · Derivative | 150,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001144204-16-136458 · v453904_4.xml · derivative · entry 3 Swanson Kent L · CIK 0001298906 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: See footnote · 150,000 shares Expires 2016-11-14 F1 · derivative.underlying: The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by the Issuer to all holders of the Issuer's common stock and outstanding convertible notes. Each holder received 2 subscription rights per share of stock owned, and each right allowed the recipient to purchase one unit, consisting of one share of common stock and one warrant to purchase one share of common stock. The subscription price per unit was $0.75. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.